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Abstract
Background: Maternal cytomegalovirus (CMV) and rubella infections have adverse neonatal outcomes. Basic
epidemiological data concerning CMV and rubella is necessary for health planners and care providers.
Methods: A cross sectional study was conducted at El-Rahad hospital, Sudan to investigate seroprevalence of CMV
and rubella infections and associated possible risk factors among pregnant women. Structured questionnaires were
used to gather socio-demographic data and ELISA was used to detect CMV and rubella infections using IgG and
IgM.
Results: Out of 231 pregnant women, 167 (72.2%) and 151 (65.3%) were CMV-IgG and rubella-IgG positive,
respectively. Only 6 (2.5%) and 8 women (3.4%) were CMV-IgM and rubella-IgM positive, respectively. While, high
parity (OR = 14.7, 95%CI = 1.7 - 123.6; P = 0.01] and illiteracy (OR = 3.0, CI = 1.4 - 6.5; P = 0.004) were significantly
associated with seropostive CMV-IgG in multivariate analysis, none of the other obstetrical and medical
characteristics were significantly associated with CMV or rubella infections.
Conclusion: CMV prevalence was 72.2% and rubella susceptibility among pregnant women was 34.6%. Rubella
vaccine and routine screening for rubella and CMV should be introduced for pregnant women in this setting.
Further research is needed.
Introduction
Maternal Cytomegalovirus (CMV) is the commonest
viral infection in perinatal period and it is the leading
cause for congenital CMV infection with a permanent
hearing, vision loss and neurological impairment [1-3].
It have been reported that, Africa continent have one of
the highest prevalence of CMV e.g. in neighboring
Egypt, CMV seroprevalence among pregnant women
was 96% [3,4]. Maternal sexual behavior and contact
with infected young children were the known source of
infection [5]. While CMV has asymptomatic infection,
rubella infection is mild or self limiting disease, trans-
mitted through respiratory system and to growing fetus
through placenta [6,7]. Maternal infection especially
during the first trimester associated with adverse neona-
tal outcome which encompass heart disease, cataract
and deafness collectively known as congenital rubella
syndrome which had a major neonatal morbidity and
burden to families [8]. Although, incidence of rubella
infection is reduced worldwide, some African countries
like Mozambique still has a high incidence (95.3%)
[9,10]. Rubella vaccine is cost-effective and cost-benefi-
cial, therefore since year 2000 WHO proposed an intro-
duction of rubella vaccine program in each country [11].
There is no published data concerning CMV and
rubella seroprevalence in pregnant women in Sudan.
The basic data concerning CMV and rubella infections
during pregnancy is important for health planners and
care providers. Thus, this was the aim of the current
study as to investigate seroprevalence, associated possi-
ble risk factors for CMV and rubella infections among
pregnant women in west Sudan. This work is the part
of collaborative projects between University of Khar-
toum and Ministry of Health Sudan so as to provide the
later with basic data necessary for intervention [12].
Methods
This was a cross-sectional study conducted at Antenatal
Care Clinic of El-Rahad hospital, western Sudan during
the period of August - October 2009. Consecutive preg-
nant women were approached to participate in the
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cal, obstetrical, socio-demographic characteristics were
gathered using pre-tested questionnaires. Women were
inquired for history of Jaundice and miscarriage. Body
mass index (BMI) was calculated by measuring weight
and height. Five mls of blood were collected in plain
tubes, allowed to clot and centrifugated at room tem-
perature. Then sera were stored at -20°C till transported
to Khartoum in dry ice for analyses. Enzyme-linked
immunosorbent assay (ELISA) was used for CMV and
rubella (IgG and IgM) using commercial diagnostic kits
(DRG Instruments GmbH. Germany). Quantitative ana-
lysis for CMV and rubella (IgG and IgM) were per-
formed, and the assay result interpreted as IU/mL. The
manufacturer’s instructions were followed for the cutoff
points, which was < 9 IU/mL for CMV IgG and IgM.
Results < 10 and (< 68 IU/mL was considered negative
for rubella IgG and IGM, respectively.
Statistics
Data were entered in the computer using SPSS for win-
dows version16.0 and double checked before analysis.
Means and proportions of the socio-demographic and
obstetrical characteristics were calculated for CMV and
rubella seropostive groups. Univariate and multivariate
analysis were used for CMV and rubella IgG seropostive
groups as dependent variable and socio-demographic
and obstetrics variables as independent variables. P
value < 0.05 was considered significant.
Result
Socio-demographic and clinical characteristics
A total of 231 pregnant women were enrolled to the
study. The mean (SD) of age, parity and gestational age
were 25.7 (5.9) years, 2.5 (2.1), 25.5(9.6) weeks, respec-
tively. More than third (39.4%) of these women were illit-
erate. Forty-five (19.5%) women has history of
miscarriage and 60 (26%) had past history of jaundice,
table 1.
CMV and rubella seroprevalence
Out of these 231 pregnant women, 167 (72.2%) and 6
(2.5%) had seropostive CMV IgG and IgM, respectively.
A total 151 (65.3%) and 8 (3.4%) women had seropostive
rubella IgG and IgM, respectively. For both CMV and
rubella, those women with IgM positive had IgG positive
too. One hundred-eight (46.75%) women had IgG posi-
tive for both CMV and rubella.
Risk factors for CMV and rubella virus
Univariate and multivariate analysis showed that both
illiteracy (OR = 3.0, CI = 1.4-6.5; P = 0.004) high parity
[> 5 deliveries] (OR = 14.7, CI = 1.7 - 123.6; P = 0.01)
were significant risk factors for CMV infection. Age was
Table 1 Obstetrical, socio-demographical and clinical characteristic of the pregnant women in El-Rahad Hospital
Western Sudan
Variables Total (N= 231) Cytomegalovirus seropostive (N= 167) Rubella seropostive (N = 151)
Age (years) 25.7 (5.9) 26.5 (5.94) 25.6 (5.8)
Haemoglobin (g/dl) 11.1 (1.6) 11.09 (1.6) 11.1 (1.6)
Parity 2.5 (2.1) 3.09 (2.1) 2.5 (2.1)
Gestational age (weeks) 25.5 (9.6) 26.13 (9.4) 26.24 (9.3)
Body mass index 24 (23) 24.65 23 (4.8)
Education level
Illiterate 91 (39.4) 78 (46.7) 65 (43)
Primary 100 (43.3) 70 (41.9) 67 (44.4)
Secondary 31 (13.4) 17 (10.2) 14 (9.3)
University 9 (3.9) 2 (1.2) 5 (3.3)
Occupation
House wife 104 (45.2) 72 (43.1) 69 (45.7)
Farmer 114 (49.4) 90 (53.9) 76 (50.3)
Employee 12 (5.2) 5 (3) 6 (4)
History of Miscarriage
Yes 45 (19.5) 38 (22.8) 31 (20.5)
No 179 (77.5) 126 (75.4) 117 (77.5)
History of Jaundice
Yes 60 (26) 42 (25.1) 40 (26.5)
No 171 (74) 125 (74.9) 111 (73.5)
Data are expressed as Mean (SD) or number (percentage).
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analyses. Gestational age, history of miscarriage, past
history of jaundice, hemoglobin level and body mass
index were not significantly associated with CMV infec-
tion, table 2. While illiteracy was significantly associated
with rubella infection in univariate analyses, none of the
investigated socio-demographic obstetrical factors were
associated with rubella in multivariate analyses, table 3.
Discussion
To our knowledge this the first published data in Sudan
concerning epidemiology of CMV and rubella among
pregnant women. In the current study, the prevalence of
CMV IgG was 72.2%. The prevalence of CMV IgG
among pregnant women was reported to be higher in
other African countries e.g. 97.2% in Benin [13], 96% in
Egypt [4], and 87% in Gambia [14]. However, much
higher prevalence of CMV was reported in South East
Asia [15], while European countries show low preva-
lence [16]. The low prevalence of CMV in this setting
could be explained; firstly by the difference of HIV
(which is important co-infection with CMV) prevalence
in these settings [17-21]. We have recently observed a
low HIV prevalence among pregnant Sudanese women
[18]. Secondly, the different socio-demographic, various
cultures and behaviors among these settings might have
influence and determine epidemiology of CMV e.g.
practice of breast feeding, child care and sexual activity
[22-24].
R u b e l l ap r e v a l e n c ei nt h i ss t u d yw a s6 5 . 3 % ,h e n c e
34.7% of the pregnant women are at risk for rubella
infection and their unborn babies are vulnerable to con-
genital rubella syndrome. However, this prevalence is in
concert with those reported from Nigeria 68.5% [25].
Although, there is a high prevalence of CMV all over
the world, there is no available vaccine for CMV up to
the moment. On the other hand, rubella vaccine - is not
yet recommended in Sudan-has been licensed since
1969 [26].
In the current study illiterate women and women with
high parity were at higher risk for CMV infection. High
parity and illiteracy were observed before as risk factors
for increased susceptibility to acquisition CMV infec-
tion, perhaps through the direct contact with contagious
secretions from their own children and poor hygiene
practiced by these women [27-30]. Likewise, low socio-
economic status has been found as a strong risk factor
for acquisition CMV infection [28]. Nevertheless in
Sudan it is difficult to investigate the socio-economic
status of these pregnant women because the culture is
based on generous hospitality attitude toward guest and
family members who usually lives in extended families.
In the current study age was not significantly asso-
ciated with CMV or rubella infections. There is a lot of
debate concerning maternal age and CMV infection;
while many investigators observed that, elder women
were at higher risk of CMV infection [28], others
reported the reverse [31]. However, Bukbuk et al., docu-
mented that, increasing maternal age was significantly
associated with rubella infection among Nigerian
women [32].
The current study has many limitations; one of these
we did not use Polymerase Chain Reaction (PCR) of the
viral DNA isolation. The other limitation is the lack of
follow-up for these women in order to document sero-
converation and to detect fetal infections.
Conclusion
This study show the prevalence of 72.2% and 65.3% of
CMV and rubella infections among pregnant women in
western of Sudan respectively, illiteracy and high parity
are the risk factors for CMV infection. Rubella vaccine
is recommended for childbearing age women. More
research is needed.
Table 2 Factors associated with cytomegalovirus (CMV)
infection in pregnancy in El-Rahad hospital, Western
Sudan, using Univariate and multivariate analysis.
Variables Univariate analysis Multivariate analysis
OR 95% CI P
value
OR 95% CI P
value
Age 1.1 1.0 - 1.1 <0.001 1.0 0.9 - 1.0 0.6
Illiteracy 3.4 1.7 - 6.7 <0.001 3.0 1.4 - 6.5 0.004
Gestational age 1.0 0.9 - 1.0 0.1 1.0 0.9 - 1.0 0.3
High parity 22.5 3.0 -
167.3





2.2 0.9 - 5.4 0.06 1.5 0.5 - 4.4 0.3
History of jaundice 0.8 0.4 - 1.6 0.6 0.5 0.2 - 1.1 0.1
Haemoglobin 0.9 0.7 - 1.0 0.2 0.8 0.6 - 1.0 0.2
Body mass index 1.0 0.9 - 1.0 0.6 1.0 0.9 - 1.0 0.4
Abbreviations: OR, Odds Ratio; CI, confidence interval
Table 3 Factors associated with Rubella virus infection in
pregnancy in El-Rahad hospital Western Sudan, using
Univariate and multivariate analysis.
Variables Univariate analysis Multivariate analysis
OR 95% CI P value OR 95% CI P value
Age 0.9 0.9 - 1.0 0.7 1.0 0.9 - 1.1 0.4
Educational level 0.6 0.4 - 0.9 0.02 0.6 0.4 - 1.0 0.08
Gestational age 1.0 0.9 - 1.0 0.1 1.0 0.9 - 1.0 0.4
Parity 1.0 0.8 - 1.1 0.9 0.9 0.7 - 1.1 0.5
History of miscarriage 1.1 0.5 - 2.3 0.6 1.2 0.5 - 2.8 0.5
History of jaundice 1.0 0.5 - 2.0 0.8 1.2 0.6 - 2.5 0.4
Haemoglobin 0.9 0.7 - 1.1 0.4 0.9 0.7 - 1.0 0.2
Body mass index 0.9 0.9 - 1.0 0.3 0.9 0.9 - 1.0 0.5
Abbreviations: OR, Odds Ratio; CI, confidence interval
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